159 related articles for article (PubMed ID: 8047825)
21. Review article: acidity and volume of the refluxate in the genesis of gastro-oesophageal reflux disease symptoms.
Sifrim D; Mittal R; Fass R; Smout A; Castell D; Tack J; Gregersen H
Aliment Pharmacol Ther; 2007 May; 25(9):1003-17. PubMed ID: 17439501
[TBL] [Abstract][Full Text] [Related]
22. Automated oesophageal reflux sampler--a new device used to monitor bile acid reflux in patients with gastro-oesophageal reflux disease.
Nehra D; Watt P; Pye JK; Beynon J
J Med Eng Technol; 1997; 21(1):1-9. PubMed ID: 9080355
[TBL] [Abstract][Full Text] [Related]
23. Effect of hiatal hernia on proximal oesophageal acid clearance in gastro-oesophageal reflux disease patients.
Emerenziani S; Habib FI; Ribolsi M; Caviglia R; Guarino MP; Petitti T; Cicala M
Aliment Pharmacol Ther; 2006 Mar; 23(6):751-7. PubMed ID: 16556177
[TBL] [Abstract][Full Text] [Related]
24. The roles of excessive gastro-oesophageal reflux, disordered oesophageal motility and decreased mucosal sensitivity in the pathogenesis of Barrett's oesophagus.
Niemantsverdriet EC; Timmer R; Breumelhof R; Smout AJ
Eur J Gastroenterol Hepatol; 1997 May; 9(5):515-9. PubMed ID: 9187887
[TBL] [Abstract][Full Text] [Related]
25. Review article: role of pepsin and bile in gastro-oesophageal reflux disease.
Tack J
Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():48-54. PubMed ID: 16042659
[TBL] [Abstract][Full Text] [Related]
26. Short exposure of oesophageal mucosa to bile acids, both in acidic and weakly acidic conditions, can impair mucosal integrity and provoke dilated intercellular spaces.
Farré R; van Malenstein H; De Vos R; Geboes K; Depoortere I; Vanden Berghe P; Fornari F; Blondeau K; Mertens V; Tack J; Sifrim D
Gut; 2008 Oct; 57(10):1366-74. PubMed ID: 18593808
[TBL] [Abstract][Full Text] [Related]
27. Intra-oesophageal acid suppression in complicated gastro-oesophageal reflux disease: esomeprazole versus lansoprazole.
Frazzoni M; Manno M; De Micheli E; Savarino V
Dig Liver Dis; 2006 Feb; 38(2):85-90. PubMed ID: 16289976
[TBL] [Abstract][Full Text] [Related]
28. Cisapride inhibits meal-stimulated gastric acid secretion and post-prandial gastric acidity in subjects with gastro-oesophageal reflux disease.
Gardner JD; Rodriguez-Stanley S; Robinson M; Miner PB
Aliment Pharmacol Ther; 2002 Oct; 16(10):1819-29. PubMed ID: 12269977
[TBL] [Abstract][Full Text] [Related]
29. The refluxate: The impact of its magnitude, composition and distribution.
Woodland P; Sifrim D
Best Pract Res Clin Gastroenterol; 2010 Dec; 24(6):861-71. PubMed ID: 21126699
[TBL] [Abstract][Full Text] [Related]
30. Fatty acid profile of oesophageal mucosa in children with gastro-oesophageal reflux disease.
D'Eufemia P; Celli M; Finocchiaro R; Troiani P; Tote J; Giardini O; Corrado G
Dig Liver Dis; 2003 Oct; 35(10):694-700. PubMed ID: 14620617
[TBL] [Abstract][Full Text] [Related]
31. The fractal nature of human gastro-oesophageal reflux.
Gardner JD; Young W; Sloan S; Robinson M; Miner PB
Aliment Pharmacol Ther; 2005 Nov; 22(9):823-30. PubMed ID: 16225491
[TBL] [Abstract][Full Text] [Related]
32. Combined gastric and oesophageal 24-hour pH monitoring and oesophageal manometry in patients with reflux disease, resistant to treatment with omeprazole.
Klinkenberg-Knol EC; Meuwissen SG
Aliment Pharmacol Ther; 1990 Oct; 4(5):485-95. PubMed ID: 2129636
[TBL] [Abstract][Full Text] [Related]
33. Normal values and day-to-day variability of 24-h ambulatory oesophageal impedance-pH monitoring in a Belgian-French cohort of healthy subjects.
Zerbib F; des Varannes SB; Roman S; Pouderoux P; Artigue F; Chaput U; Mion F; Caillol F; Verin E; Bommelaer G; Ducrotté P; Galmiche JP; Sifrim D
Aliment Pharmacol Ther; 2005 Nov; 22(10):1011-21. PubMed ID: 16268977
[TBL] [Abstract][Full Text] [Related]
34. Contribution of acid and duodenogastro-oesophageal reflux to oesophageal mucosal injury and symptoms in partial gastrectomy patients [see comment].
Vaezi MF; Richter JE
Gut; 1997 Sep; 41(3):297-302. PubMed ID: 9378381
[TBL] [Abstract][Full Text] [Related]
35. Endoscopic appearance of GERD: putative role of cell proliferation.
Calabrese C; Trerè D; Fabbri A; Cenacchi G; Vici M; Derenzini M; Di Febo G
Dig Liver Dis; 2007 Aug; 39(8):713-9. PubMed ID: 17606421
[TBL] [Abstract][Full Text] [Related]
36. Relationship between acceleration of gastric emptying and oesophageal acid exposure in patients with endoscopy-negative gastro-oesophageal reflux disease.
Carmagnola S; Fraquelli M; Cantù P; Conte D; Penagini R
Scand J Gastroenterol; 2006 Jul; 41(7):767-72. PubMed ID: 16785188
[TBL] [Abstract][Full Text] [Related]
37. Non-erosive reflux disease (NERD)--acid reflux and symptom patterns.
Martinez SD; Malagon IB; Garewal HS; Cui H; Fass R
Aliment Pharmacol Ther; 2003 Feb; 17(4):537-45. PubMed ID: 12622762
[TBL] [Abstract][Full Text] [Related]
38. Investigation of oesophageal reflux symptoms after gastric surgery with combined pH and bilirubin monitoring.
Marshall RE; Anggiansah A; Owen WA; Owen WJ
Br J Surg; 1999 Feb; 86(2):271-5. PubMed ID: 10100802
[TBL] [Abstract][Full Text] [Related]
39. [The relationship between oesophageal and gastric pH during 24-hours pH-metry in patients diagnosed with atypical chest pain].
Klopocka M; Budzński J; Swiatkowski M; Pulkowski G
Pol Arch Med Wewn; 2005 Feb; 113(2):111-8. PubMed ID: 16209231
[TBL] [Abstract][Full Text] [Related]
40. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
